here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
>General
Human EditedGeneral: Some of the directoried dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
are very general according to category, language, region etc. some of are restricted t
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
o their specific area like music directory, hosting directories, reciprocal link etc. e
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
amples of well known general directories are yahoo, dmoz etc. Directories have various
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
type of listing:
- Free submission
- Featured link
- Paid link
<
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
i>Reciprocal link etc.Human Edited directories Human edited
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
directory is basically a kind of general web directories. The difference is it is maint
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
ained by the editors and the link added to these directories on the policies of the dir
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
ctories. Human edited directories are basically targeted for the purpose of improve ran
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
king in the search engines by the SEO’s. links added to these directories by the webmas
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
er of the directory
Future of Web Directory Web Directory plays an im
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
portant role in the field of search engine marketing and SEO too. In terms of search en
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
ine marketing the response of web directories are quite slow. Once it started giving re
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
sults it much more than expectations mostly the human edited directories. Human edited
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
irectories given the more value than others.
Overall we can say that web directories n
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
ot only help to improve, but also help create growth in the world of internet marketing
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products